Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice
Objective: Type 1 diabetes (T1D) occurs because of islet infiltration by autoreactive immune cells leading to destruction of beta cells and it is becoming evident that beta cell dysfunction partakes in this process. We previously reported that genetic deletion and pharmacological antagonism of the c...
Saved in:
Main Authors: | Kanikkai Raja Aseer (Author), Caio Henrique Mazucanti (Author), Jennifer F. O'Connell (Author), Isabel González-Mariscal (Author), Anjali Verma (Author), Qin Yao (Author), Christopher Dunn (Author), Qing-Rong Liu (Author), Josephine M. Egan (Author), Máire E. Doyle (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to "Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice" [Mol Metab 82 (2024 April) 101906]
by: Kanikkai Raja Aseer, et al.
Published: (2024) -
Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
by: Qing-Rong Liu, et al.
Published: (2022) -
5-HT2A deletion protects against Clozapine-induced hyperglycemia
by: Radhika Sudhir Joshi, et al.
Published: (2019) -
Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy?
by: F. Fahmideh, et al.
Published: (2022) -
Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia
by: Belen Rivero-Gutierrez, et al.
Published: (2018)